• Open Access
    Retraction

    Retraction: Diffusion magnetic resonance imaging-based surrogate marker in amyotrophic lateral sclerosis

    Explor Neuroprot Ther. 2023;3:513 DOI: https://doi.org/10.37349/ent.2023.00066

    Received: Accepted: Published: December 29, 2023

    Retraction to “Diffusion magnetic resonance imaging-based surrogate marker in amyotrophic lateral sclerosis” by Saito Y. Explor Neuroprot Ther. 2023;3:186–206. DOI: 10.37349/ent.2023.00047

    The original article was retracted by the Journal due to excessive unreferenced overlapping of text and similarity in Figures with another previously published article [1].

    This retraction was approved by the Editor-in-Chief.

    The publisher regrets that this issue was not identified by the usual quality checks before publication and plans to take additional measures to safeguard research integrity.

    References

    Kamagata K, Andica C, Kato A, Saito Y, Uchida W, Hatano T, et al. Diffusion magnetic resonance imaging-based biomarkers for neurodegenerative diseases. Int J Mol Sci. 2021;22:5216. [DOI] [PubMed] [PMC]
    • Citation
      Cite this Article
      • Article Metrics
      • View: 414
      • Download: 26
      • Times Cited: 0